Ennature Bio Pharma Ltd logo

Ennature Bio Pharma Ltd (ENNATURE) share fundamentals

UnknownlistedNSE / BSE

Ennature Bio Pharma Ltd is a listed company in Unknown with a market capitalisation of —. Here is where it stands on valuation, profitability, debt and growth as of 5 November 2026, and how it compares with the median Unknown company.

Share price₹239.15
Market cap—
PE ratio—
ROCE0%
Debt / equity—
1-year return-5%

Financial health score

23.1
High risk

Out of 100, across five pillars of reported fundamentals.

Profitability0
Debt & solvency0
Valuation—
Growth—
Governance100

What stands out

Ennature Bio Pharma Ltd vs the Unknown median

MetricENNATURESector median
PE ratioprice paid for each rupee of yearly profit—0x
Price to bookprice against the book value of assets—0x
EV / EBITDAbusiness value against operating profit—2x
Dividend yieldyearly dividend as a share of price——
Return on equityprofit on shareholders’ money—2.9%
ROCEprofit on all capital employed0%4.8%Weaker
Net profit marginprofit kept from each rupee of sales—6%
Debt to equityborrowing against shareholders’ money—0.02x
Interest coveragehow many times profit covers interest—2.33x
Current ratioshort-term assets against short-term dues0x2xWeaker
Revenue growth (1Y)change in sales over a year—4.2%
EPS growth (1Y)change in earnings per share over a year—3.4%
Promoter holdingshare owned by the founders or parent59.6%53.7%Better
Promoter pledgepromoter shares pledged as loan security0%0%In line
Betahow much it moves with the market——
1-year returnshare price change over 52 weeks-5%0%
Want a plan built around your money?

Tell DecideChart your amount, timeline and target return, and AI builds a full A4 report with risks, scenarios and worst cases. Your first report is free.

Decide · where to investOpen on the chart

Other Unknown companies

See all Unknown stocks →

Frequently asked questions

What is the PE ratio of Ennature Bio Pharma Ltd?

A PE ratio is not available for Ennature Bio Pharma Ltd as of 5 November 2026, usually because the company is loss-making.

Is Ennature Bio Pharma Ltd debt free?

Debt data is not available for Ennature Bio Pharma Ltd.

What is the ROCE and ROE of Ennature Bio Pharma Ltd?

Ennature Bio Pharma Ltd has a return on capital employed of 0% and a return on equity of —. The Unknown medians are 4.8% and 2.9%.

What is the DecideChart health score of Ennature Bio Pharma Ltd?

Ennature Bio Pharma Ltd scores 23.1 out of 100, graded High risk. The score weighs profitability, debt, valuation, growth and governance from the company’s reported numbers. It is a research aid, not a recommendation.

Should I buy Ennature Bio Pharma Ltd shares?

DecideChart does not give buy or sell tips and is not linked to SEBI, BSE or NSE. Use these numbers for your own research, compare Ennature Bio Pharma Ltd with its Unknown peers, and consult a SEBI-registered adviser before investing.

Fundamentals from a public market-data screener, as of 5 November 2026. Figures can lag company filings. DecideChart is AI-based, not linked to SEBI, BSE or NSE, and does not give investment advice.